| ACD | Allergic contact dermatitis |
| ACGIH | American Conference of Governmental Industrial Hygienists |
| AFE | Adjustment factor for exposure considerations |
| AFH | Adjustment factor for translation to human effects |
| AFIV | Adjustment factor for interindividual variability |
| AOP | Adverse outcome pathway |
| ARE | Antioxidant response element |
| CASRN | Chemical Abstract Service Registry Number |
| CD54 | Cluster of differentiation 54 |
| CD86 | Cluster of differentiation 86 |
| cm2 | Square centimeters |
| CV75 | 75% cell viability |
| DPRA | Direct Peptide Reactivity Assay |
| EC1.5 | Concentration at 1.5-fold luciferase induction in KeratinoSens™ |
| EC150 | Concentration at 150% relative fluorescence intensity in human cell line activation test |
| EC200 | Concentration at 200% relative fluorescence intensity in human cell line activation test |
| EC3 | Three-fold effective concentration in local lymph node assay |
| EC3.0 | Concentration at 3.0-fold luciferase induction in KeratinoSens™ |
| EESOH-MIS | Enterprise Environmental, Safety, and Occupational Health Management Information System |
| FITC | fluorescein isothiocyanate |
| GHS | Globally Harmonized System |
| GPMT | Guinea pig maximization test |
| HaCaT | Transfected immortalized human keratinocytes |
| h-CLAT | Human cell line activation test |
| IC30 | Concentration resulting in 30% reduction in cell viability in KeratinoSens™ |
| IC50 | Concentration resulting in 50% reduction in cell viability in KeratinoSens™ |
| Imax | Maximum fold luciferase induction in KeratinoSens™ |
| k-DPRA | Kinetic direct peptide reactivity assay |
| Keap1 | Kelch-like ECH-associated protein 1 |
| kmax | Maximal rate of depletion in the kinetic direct peptide reactivity assay |
| LLNA | Local lymph node assay |
| mg/100 cm2 | Milligrams per 100 square centimeters |
| mL | Milliliters |
| mM | Millimolar |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide |
| NAM | New approach methodology |
| NESIL | No expected sensitization induction level |
| NIOSH | National Institute for Occupational Safety and Health |
| Nrf2 | Nuclear factor-erythroid 2-related factor 2 |
| OECD | Organisation for Economic Co-operation and Development |
| OSHA | Occupational Safety and Health Administration |
| PCSG | Preliminary candidate surface guideline |
| pEC3 | Preliminary three-fold effective concentration |
| PI | propidium iodide |
| POD | Point of departure |
| QSAR | Quantitative structure-activity relationship |
| RFI | Relative fluorescence intensity |
| USAF | United States Air Force |
| VP | Vapor pressure |
| w/v % | Percent weight by volume |
| WoE | Weight of evidence |
| µg/100 cm2 | Micrograms per 100 square centimeters |
| µg/mL | Micrograms per milliliter |
| µM | Micromolar |